Macquarie Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.1M | Buy |
4,807,351
+130,729
| +3% | +$956K | 0.04% | 505 |
|
2025
Q1 | $44.4M | Buy |
4,676,622
+864,393
| +23% | +$8.2M | 0.06% | 437 |
|
2024
Q4 | $62.8M | Sell |
3,812,229
-12,389
| -0.3% | -$204K | 0.08% | 353 |
|
2024
Q3 | $56.4M | Buy |
3,824,618
+561,232
| +17% | +$8.28M | 0.06% | 416 |
|
2024
Q2 | $45.3M | Sell |
3,263,386
-760,123
| -19% | -$10.5M | 0.05% | 443 |
|
2024
Q1 | $63.3M | Sell |
4,023,509
-57,670
| -1% | -$907K | 0.07% | 361 |
|
2023
Q4 | $66M | Buy |
4,081,179
+1,062,226
| +35% | +$17.2M | 0.08% | 358 |
|
2023
Q3 | $37.1M | Buy |
3,018,953
+748,900
| +33% | +$9.21M | 0.05% | 488 |
|
2023
Q2 | $36.5M | Buy |
2,270,053
+245,699
| +12% | +$3.95M | 0.04% | 527 |
|
2023
Q1 | $35.2M | Buy |
2,024,354
+55,780
| +3% | +$971K | 0.04% | 531 |
|
2022
Q4 | $18.2M | Buy |
1,968,574
+50,298
| +3% | +$465K | 0.02% | 706 |
|
2022
Q3 | $16.5M | Buy |
1,918,276
+33,262
| +2% | +$287K | 0.02% | 729 |
|
2022
Q2 | $15.4M | Sell |
1,885,014
-105,593
| -5% | -$861K | 0.02% | 759 |
|
2022
Q1 | $24.2K | Buy |
1,990,607
+606,003
| +44% | +$7.36K | 0.02% | 722 |
|
2021
Q4 | $47.2M | Sell |
1,384,604
-657,852
| -32% | -$22.4M | 0.04% | 533 |
|
2021
Q3 | $98.5M | Buy |
2,042,456
+1,170,745
| +134% | +$56.5M | 0.08% | 304 |
|
2021
Q2 | $39.4M | Buy |
871,711
+867,877
| +22,636% | +$39.2M | 0.03% | 603 |
|
2021
Q1 | $185K | Sell |
3,834
-385
| -9% | -$18.6K | ﹤0.01% | 1724 |
|
2020
Q4 | $227K | Hold |
4,219
| – | – | ﹤0.01% | 1632 |
|
2020
Q3 | $156K | Hold |
4,219
| – | – | ﹤0.01% | 1673 |
|
2020
Q2 | $131K | Buy |
4,219
+1,046
| +33% | +$32.5K | ﹤0.01% | 1670 |
|
2020
Q1 | $88K | Buy |
+3,173
| New | +$88K | ﹤0.01% | 1665 |
|
2019
Q1 | – | Sell |
-863
| Closed | -$11K | – | 1913 |
|
2018
Q4 | $11K | Buy |
+863
| New | +$11K | ﹤0.01% | 1906 |
|